10x Genomics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
10x Genomics, Inc. (TXG) had Deferred Tax Assets, Operating Loss Carryforwards of $202.70 million as of 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-13
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $202.70M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $161.68M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $166.61M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $175.02M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $202.70M 10-K · filed 2026-02-13 |
| 2024-12-31 | $161.68M 10-K · filed 2026-02-13 |
| 2023-12-31 | $166.61M 10-K · filed 2025-02-13 |
| 2022-12-31 | $175.02M 10-K · filed 2024-02-15 |
| 2021-12-31 | $195.95M 10-K · filed 2023-02-16 |
| 2020-12-31 | $90.56M 10-K · filed 2022-02-18 |
| 2019-12-31 | $28.88M 10-K · filed 2021-02-26 |
| 2018-12-31 | $31.03M 10-K · filed 2020-02-27 |